Open access · US-GOV via ClinicalTrials.gov Clinical trial

Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale

Authors not listed

Teva Branded Pharmaceutical Products R&D, Inc. · 2009

Loss of proteostasis Human Randomized controlled trial

Abstract

The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed. The consistency and accuracy of the questionnaires will also be examined. It is hypothesized that there will not be a difference.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Anonymous. (2009). Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale. <em>Teva Branded Pharmaceutical Products R&D, Inc.</em>. https://clinicaltrials.gov/study/NCT00932581

Vancouver

Anonymous. Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale. Teva Branded Pharmaceutical Products R&D, Inc.. 2009.

BibTeX

@misc{anon2009Invest, title = {Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale}, author = {Anonymous}, journal = {Teva Branded Pharmaceutical Products R&D, Inc.}, year = {2009}, }